ArticleSignal transduction and targeted therapy2022

Pro-senescence neddylation inhibitor combined with a senescence activated β-galactosidase prodrug to selectively target cancer cells.

Shuaishuai Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.